India
· Delayed Price · Currency is INR Mangalam Drugs & Organics Statistics
Total Valuation
NSE:MANGALAM has a market cap or net worth of INR 1.22 billion. The enterprise value is 2.15 billion.
| Market Cap | 1.22B |
| Enterprise Value | 2.15B |
Important Dates
The next estimated earnings date is Friday, May 30, 2025.
| Earnings Date | May 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 6.88M |
Valuation Ratios
The trailing PE ratio is 11.96.
| PE Ratio | 11.96 |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 21.12 |
| EV / Sales | 0.62 |
| EV / EBITDA | 8.69 |
| EV / EBIT | 9.94 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 4.01 |
| Debt / FCF | n/a |
| Interest Coverage | 1.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.70% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.03M |
| Profits Per Employee | 235,912 |
| Employee Count | 432 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.88% in the last 52 weeks. The beta is 0.97, so NSE:MANGALAM's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -24.88% |
| 50-Day Moving Average | 83.82 |
| 200-Day Moving Average | 107.91 |
| Relative Strength Index (RSI) | 40.15 |
| Average Volume (20 Days) | 23,780 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MANGALAM had revenue of INR 3.47 billion and earned 101.91 million in profits. Earnings per share was 6.44.
| Revenue | 3.47B |
| Gross Profit | 1.53B |
| Operating Income | 216.46M |
| Pretax Income | 70.80M |
| Net Income | 101.91M |
| EBITDA | 230.91M |
| EBIT | 216.46M |
| Earnings Per Share (EPS) | 6.44 |
Balance Sheet
The company has 60.86 million in cash and 994.39 million in debt, giving a net cash position of -933.53 million.
| Cash & Cash Equivalents | 60.86M |
| Total Debt | 994.39M |
| Net Cash | -933.53M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.48B |
| Book Value Per Share | 93.52 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 44.24%, with operating and profit margins of 6.24% and 2.94%.
| Gross Margin | 44.24% |
| Operating Margin | 6.24% |
| Pretax Margin | 2.04% |
| Profit Margin | 2.94% |
| EBITDA Margin | 6.66% |
| EBIT Margin | 6.24% |
| FCF Margin | n/a |
Dividends & Yields
NSE:MANGALAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 8.36% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |